XML 45 R45.htm IDEA: XBRL DOCUMENT v3.20.1
RELATED PARTY TRANSACTIONS (Details Narrative) - USD ($)
1 Months Ended 3 Months Ended 12 Months Ended
Jan. 27, 2020
Mar. 31, 2020
Mar. 31, 2019
Dec. 31, 2019
Dec. 20, 2018
Feb. 18, 2019
Jul. 21, 2009
Revenue   $ 11,933,248 $ 9,683,341        
Shares issued   13,225,387   13,225,387    
Officers and directors [Member]              
Shares issued             2,000,000
Decahedron [Member]              
Revenue from DOC Pharma   $ 215,648          
Grigorios Siokas Four [Member]              
Loans payable       $ 722,762    
Additional proceeds from debt   380,000          
Grigorios Siokas Three [Member]              
Loans payable       303,502    
Outstanding principal balance   1,487,807   1,026,264      
Additional proceeds from debt   136,819          
Repayment of loans   49,572          
Foreign currency translation   (5,704)          
DOC Pharma S.A. [Member]              
Accounts receivable balance   569,903   601,738      
Accounts payable balance   33,627   24,870      
Prepaid balance   2,343,924   2,403,449      
Net prepaid balance   2,310,296   2,377,731      
Payments to acquire businesses   670,631 576,089        
Revenue   145,896 $ 183,333        
DOC Pharma S.A. [Member] | Loan Agreement [Member] | November 1, 2015 [Member]              
Loans payable   12,662          
Outstanding principal balance   13,219   13,472      
Payment made for existing bills   $ 12,662          
Interest rate   2.00%          
Accrued interest   $ 1,166   1,100      
Foreign currency translation loss   (25,851)          
Dimitrios Goulielmos [Member]              
Outstanding principal balance   11,237   14,820      
Repayment of loans   3,305   45,245      
Grigorios Siokas [Member] | January Note [Member] | Senior Promissory Note [Member]              
Loans payable   2,500,000        
Outstanding principal balance   1,321,920   1,347,240      
Interest rate 5.00%       4.70%    
Accrued interest   2,226   $ 139,530      
Borrowing       $ 1,718,400    
Maturity date         Mar. 18, 2019